New York Academy of Sciences and Medidata Present Mobile Health Conference, Highlighting the Power of Wearables, Sensors, and Apps to Transform Clinical Trials

New York, NY - September 24, 2015 - The New York Academy of Sciences and Medidata Solutions, the leading global provider of cloud-based solutions for clinical research in life sciences, today announced a two-day conference highlighting the latest developments in mobile health (mHealth) technologies and their applications in clinical development. Mobile Health: The Power of Wearables, Sensors, and Apps to Transform Clinical Trials will be hosted at the New York Academy of Sciences on Wednesday, September 30 and Thursday, October 1, 2015. 

Researchers, regulators, technologists, academics, business leaders, and others will explore the promise wearables, biosensors, and mobile apps hold in improving the quality of patient care and clinical outcomes.

"As more and more life sciences organizations embrace mobile health technologies in their development cycles, we will have the ability to collect nuanced, meaningful data on patients in clinical trials--a revolution that will transform drug development," said Glen de Vries, Medidata's president and a member of the conference's scientific organizing committee. "At Medidata, we are making it possible to seamlessly integrate these new types of measurements with traditional study data, enabling a more holistic view of the patient than ever before. We're excited to be partnering with the Academy on an event that will foster important dialogue on how the industry can leverage these new mHealth technologies, and how to advance the science of drug development."

The conference will feature speakers from a wide range of disciplines, including:

• Bernard Munos, MS, MBA, FasterCures, a center of the Milken Institute, and a member of the conference's scientific organizing committee;
• John Mastrototaro, PhD,Medtronic and a member of the conference's scientific organizing committee;
• Fiorenzo Omenetto, PhD, Tufts University and a member of the conference's scientific organizing committee;
• Tomasz Sablinski, MD, PhD, Transparency Life Sciences;
• Leonard Sacks, MD, US Food and Drug Administration and a member of the conference's scientific organizing committee;
• Christian Stammel, MBA, Wearable Technologies AG; and
• Pei Wang, PhD, Icahn School of Medicine at Mount Sinai.

Additional speakers will focus on groundbreaking device innovation, data optimization and validation, and commercial platform integration, as well as clinical implementation and regulation.

"Scientists will soon have data they've never had before-including phenotypic, behavioral, environmental, microbiome, and social network data-to better understand how diseases develop," says Munos. "Speed, patient-relevance, transparency, data-sharing, and convenience will soon become fixtures of drug R&D, and the organizations that do not cultivate such values will find it harder to attract the patients they need."

Dr. Sablinski added: "The potential of biosensor technologies is enormous. One can compare it to the time it takes to handwrite and mail a letter overseas versus sending an e-mail. Biopharmas and CROs are stuck in 'handwritten letters' mode, so one can imagine the impact of the clinical research enterprise switching to the age of the Internet. I look forward to joining Medidata, the Academy, and other innovative leaders from a number of fields to continue exploring the exciting future of mHealth technologies in clinical research."

To register, learn more and view a full conference agenda, visit www.nyas.org/mobilehealth2015.

For media inquiries, including press passes to the conference, please contact Diana Friedman (dfriedman@nyas.org; 212-298-8645).

About Medidata Solutions

Medidata is the leading global provider of cloud-based solutions for clinical research in life sciences, transforming clinical development through its advanced applications and intelligent data analytics. The Medidata Clinical Cloud^® brings new levels of productivity and quality to the clinical testing of promising medical treatments, from study design and planning through execution, management and reporting. We are committed to advancing the competitive and scientific goals of global customers, which include over 90% of the top 25 global pharmaceutical companies; innovative biotech, diagnostic and device firms; leading academic medical centers; and contract research organizations.

About the New York Academy of Sciences

The New York Academy of Sciences is an independent, not-for-profit organization that since 1817 has been committed to advancing science, technology, and society worldwide. With more than 20,000 members in 100 countries around the world, the Academy is creating a global community of science for the benefit of humanity. The Academy's core mission is to advance scientific knowledge, positively impact the major global challenges of society with science-based solutions, and increase the number of scientifically informed individuals in society at large. Please visit us online at www.nyas.org.

#  #  #

NYAS Contact

Media: Diana Freedman, New York Academy of Sciences, +1 212-298-8645, dfriedman@nyas.org  

Medidata Contacts
Investor: Hulus Alpay, Medidata Solutions, +1 212-419-1025, halpay@mdsol.com

Media: Nicole Pariser, Medidata Solutions, +1 212-659-1069, npariser@mdsol.com